Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-31

Clinical Trial Update: Clinical Effects of Eptifibatide Administration in High Risk Patients Presenting With Non-ST Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Urgent Coronary Artery Bypass Graft Surgery in Short- and Long-Term Follow-up [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the short- and long-term effects of eptifibatide in high-risk patients with non-ST elevation myocardial infarction undergoing …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Integrilin (Eptifibatide)

Snippet

Sponsor: Medical University of Silesia | Conditions: Non ST Elevation Myocardial Infarction | Phase 4 | Status: COMPLETED | Results posted: 2013-10-31